Initial studies for gene therapy of cystic fibrosis have used endogenous CFTR. The CFTR gene on the YAC was heterologous promoters to drive expression of the cystic found to be well expressed in the Caco-2 cells and, in the fibrosis transmembrane regulator (CFTR) cDNA. An altertwo cell lines analysed, the ratio of YAC-derived mRNA to native approach would be to have constructs based on the endogenous mRNA was the same as the ratio of YAC DNA endogenous promoter which could give tissue-specific and to endogenous DNA. This indicates that each copy of the normal, regulated levels of expression. The DNA elements CFTR gene on a YAC integrated in the Caco-2 cells is necessary for this remain unidentified so we have investibeing expressed at approximately the same level as each gated CFTR expression from a 310 kb yeast artificial chroof the endogenous genes. Thus, the YAC clone contains mosome (YAC) clone which contains the intact human all the long-range elements necessary to confer full levels CFTR gene consisting of 27 exons spread over 230 kb of of expression, independent of position of integration, in genomic DNA and also about 50 kb of 5′ DNA. In order to human Caco-2 cells. Deletion of this YAC clone should distinguish the gene on the YAC, a restriction site change allow the elucidation of the DNA elements controlling was introduced into the 3′ untranslated region of the gene human CFTR expression and the development of conin the YAC. The YAC was then transferred into the human structs for gene therapy. colonic adenocarcinoma cell line Caco-2 which expresses
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In all cystic fibrosis (CF) gene therapy trials so far pubwhich is suitable for the study of gene expression at the locus level, we have introduced a YAC (yCFTR, formerly lished, heterologous promoters driving the expression of a cystic fibrosis transmembrane regulator (CFTR) cDNA 37AB12-pLNA 11 ) into the human colonic adenocarcinoma cell line Caco-2 which expresses the CFTR gene. In this were used.
1,2 However, it may be advantageous to have a construct based on an endogenous promoter. Such report we demonstrate that when yCFTR is integrated intact into the host cell genome, the CFTR transgene is a minigene would confer tissue specificity and physiological, regulated levels of expression but the elements expressed in a copy-number dependent manner. The restriction map of yCFTR, shown in Figure 1a , is necessary have not been identified.
Previous studies involving 2.2 kb 3 or 3.8 kb 4 or 19 kb 5 consistent with the already published map of the original 37AB12 YAC 12 and is also consistent with the map of the of CFTR promoter, driving the expression of a reporter gene in transgenic mice showed that the reporter gene genomic region. 13 The mapping indicates that yCFTR contains the 230 kb human CFTR gene, flanked by about was either not expressed 4, 5 or expressed in cells where the normal CFTR transcript is not detectable. 3 Similar 50 kb of human genomic DNA on the 5′ side and 5-10 kb on the 3′ side. The YAC was also modified so that it constructs were used in transient assays in tissue culture cells, leading to a lack of consensus opinion concerning would be possible to distinguish the gene on the YAC from the endogenous gene after transfer into a human the sequences which constitute the minimal CFTR promoter.
6-8 Moreover, DNAse I hypersensitive sites have cell line. A restriction site change was introduced into the 3′ untranslated region of the CFTR gene in the YAC using been located 5′ of the gene at approximately −79.5 kb and −20.5 kb from the point of initiation of transcription 9 and the 'pop-in/pop-out' procedure, 14,15 summarised in Figure To determine whether yCFTR can express a functional CFTR protein, we initially tried to transfer the YAC into the 2CFSMEo− cell line, which was generated from lung CFTR mRNA. 16 However, in these experiments, no G418- 
CYAC-1 or CYAC-2 cells was digested with SalI which
The reaction mixes were then heated for 3 min at 94°C and then subjected only cuts in the two arms of yCFTR (Figure 1a ), releasing cloned PCR product GV4579/5508 and presented in Figure 3a, shows that a band at about 400 kb can be detected in Caco-2 genomic DNA indicating the presence of the CFTR cDNA after digestion of total yeast DNA with endogenous CFTR genes. In both CYAC-1 and CYAC-2, either EcoRI, HindIII or BamHI (not shown). The yCFTR ⌬1 an additional band at about 340 kb can be detected is therefore very likely to be identical to yCFTR but with (Figure 3a) , demonstrating that both cell lines contain a nonfunctional ura3 gene. The pop-in and pop-out colonintact copies of the yCFTR tag . Quantification of the bands ies obtained were analysed by PCR with the primers at 400 kb and 340 kb was performed on the same blot GV4579/5508 (Figure 1b) . This allowed the selection of the pop-out clone yCFTRtag which possesses a ClaI site using a phosphoimager. The ratio of intensities of the Different mixes of plasmid DNA (100 ng) containing different proportions of pGV4 (containing the ClaI site) and pGV3 (containing the BclI site) were amplified using the primers GV4570/5508 in a reaction containing 33 P-labelled dCTP (Amersham, Little Chalfont, UK) and digested for 4 h at 37°C with either BclI, ClaI or both enzymes (in 50 mm potassium acetate, 20 mm tris-acetate, 10 mm magnesium acetate, 1 mm dithiothreitol, 100 m bovine serum albumin, pH 7.9). The digests were then separated on a 2% agarose gel. The gel was then dried on to Whatmann paper and the intensity of the bands quantified using a phosphoimager (Molecular Dynamics, Chesham, UK). In these experiments, the uncut PCR product obtained after digestion by BclI was considered as representative of the DNA amplified from the YAC and the sum of the radioactivity associated with the digested bands (around 600 bp and 400 bp) was considered as representative of the DNA amplified from the endogenous Caco-2 source. Inversely, the uncut PCR band obtained after digestion with ClaI was associated with the endogenous Caco-2 source while the smaller bands were considered as representative of the DNA amplified from the YAC source. In all the experiments taken into account for the quantification, the double digestion with BclI and ClaI gave no detectable undigested product. The data are presented as the ratio of the radioactivity associated with the DNA generated from pGV4 (uncut with BclI and cut with ClaI) to the DNA generated pGV3 (cut with BclI and uncut with ClaI).
Figure 2 The 'pop-in/pop-out' procedure. The plasmid pGV3 was made by cloning the target sequence (PCR product GV4579/5508) into pGV1 (a modified version of pRS406 (Stratagene, Cambridge, UK), without a HindIII site in the polylinker). pGV3 was then digested with BclI (unique site in the plasmid and present in the genomic PCR product GV4579/5508), blunt-ending using Klenow DNA polymerase and ligation to give pGV4. This process leads to the addition of 4 bp and the creation of a ClaI site instead of the original BclI site. All these experiments were performed using standard procedures.
26 pGV4 was then transformed into yeast 27 after linearisation with HindIII to generate free ends which promote homologous recombination in yeast. 14 
The integration leads to the duplication of the targeted sequence (pop-in step). The duplicated region can undergo a spontaneous intrachromosomal recombination which can be selected by 5-FOA (pop-out step). This process leaves either the original sequence (1) or the modified sequence (2).
bands corresponding to the YAC (340 kb) and to the the double digestion with BclI and ClaI, was observed (not shown) and an accurate quantification could not be endogenous CFTR gene (400 kb) are 1.3 and 0.5 for CYAC-1 and -2, respectively (Figure 3b) .
performed. This nondigested DNA is probably due to the formation of heterodimers in the late saturation phase. The YAC copy number was also determined using ratio PCR 19 across the BclI/ClaI site in the 3′ end of the The relative amount of YAC DNA in both cell lines, CYAC-1 and CYAC-2, was obtained using the primers gene. In this technique, it is assumed that the efficiency of the amplification is determined by the pair of primers GV4579/5508 (Figure 1b) to amplify from genomic DNA. The radioactive PCR products were then digested with if there are no significant differences in GC content nor in secondary structures. 20, 21 As a result, the ratio between either BclI, ClaI or both and Figure 4a shows the digestion pattern. In addition to the expected bands, a band at the amplified products remains constant during the whole amplification process, even in the saturation about 500 bp was obtained, but this band was also present after amplification of Caco-2 cell genomic DNA phase. 20, 21 In our study, as the two species are almost identical (a 4 bp difference out of 929 bp or 1019 bp for (not shown) and did not hybridise to the cloned PCR product GV4579/5508 after Southern blotting (not GV4570/5508 or GV4321/5340, respectively) and as the primers are the same and completely homologous to both shown). The PCR product cut by BclI comes from the endogenous Caco-2 genes, while the PCR product cut by DNA templates, one can assume that the ratio between the amplified species remains constant. This is confirmed ClaI comes from the YAC. Quantification of the different bands allowed the ratio of the PCR product generated by the results presented in Table 1 where different ratios of plasmid containing the PCR product GV4570/5508 from the YAC DNA to the PCR product amplified from the endogenous Caco-2 CFTR genes to be determined with either the BclI or ClaI site (pGV3 or pGV4, respectively) were amplified with the primers (Figure 4b ). These ratios were 1.5 ± 0.3 for CYAC-1 and 0.4 ± 0.1 for CYAC-2. Similar ratios were obtained after GV4570/5508. In these experiments, the experimental ratio is in agreement with the expected theoretical ratio. only 25 cycles of amplification (not shown). Finally, we determined the level of expression from the Moreover, very similar ratios were obtained after 25 and 30 cycles of amplification (not shown). However, if the CFTR gene on the YAC relative to that from the endogenous genes. This was done using a similar PCR approach. reaction was continued to 35 cycles, a band, resistant to In these experiments, the primers GV4321/5340 ( Figure  1b ) were used as they are separated by intron 23 in the genomic DNA, and hence selectively amplify cDNA as for the ratio of YAC DNA to endogenous DNA. Similarly, in the cell line CYAC-2 the copy number of rather than genomic DNA which would contain the intron. As before, the comparative analysis was perforyCFTRtag DNA relative to Caco-2 genomic CFTR is 0.5 and 0.4 (± 0.1) (Figures 3 and 4 , respectively) and the med by digesting the PCR products with BclI or ClaI (Figure 5a ). The quantification of the different products amount of mRNA generated from yCFTRtag relative to endogenous is 0.6 (± 0.1) ( Figure 5 ). Thus, in both cell gave a ratio of YAC CFTR to genomic CFTR cDNA of 1.7 ± 0.2 for CYAC-1 and 0.6 ± 0.1 for CYAC-2 ( Figure 5b) .
lines, the ratio of mRNA produced from the YAC to that produced from the endogenous gene is the same as the In summary, the data presented in this report indicate that in the cell line CYAC-1, the amount of the YAC DNA ratio of YAC DNA to genomic DNA. This means that one intact copy of yCFTRtag integrated into the genome of relative to the endogenous DNA was found to be 1.3 and 1.5 (± 0.3) (Figures 3 and 4, respectively) . The amount of Caco-2 is able to generate the same amount of CFTR mRNA as an endogenous gene, irrespective of where it mRNA transcribed from the YAC relative to that transcribed from the endogenous Caco-2 genes was has integrated into the genome. These data demonstrate that yCFTRtag contains the main elements involved in found to be 1.7 (± 0.2) ( Figure 5 ) which is almost the same CFTR gene, the transgene has never been found expressed in cell types that are not expressing the endogenous mouse gene. 23 So, in our hands, yCFTR contains the main elements for full levels of tissue-specific expression of the CFTR gene. Moreover, as the DNAse I hypersensitive site previously described at −79.5 kb from the CFTR gene 9 is not present in the YAC (only about 50 kb 5′ of the gene are present within the yCFTR, Figure  1 ) one can exclude a major role of this site in the regulation of transcription of the CFTR gene.
The YAC we have developed in this study (yCFTRtag) can also be modified by homologous recombination in yeast and introduced into Caco-2 cells to test the effects of targeted alterations such as removal of introns or deletion of the DNAse I hypersensitive sites. Thus, we hope to use the combined approach of tissue culture and transgenics to delineate the minimal requirements for efficient and tissue-specific expression of the CFTR gene, and to compact this information into a minigene that can be inserted into gene therapy vectors to give full levels of controlled and tissue-specific expression of the CFTR gene.
the regulation of full levels of expression of the CFTR (CHO) cells in tissue culture. 22 The two CHO stable cells not expressed in certain cell types expressing the mouse
